Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial fn1fn1This study was supported by Genentech, Inc., South San Francisco, California; Bayer Corporation, New York, New York; CIBA-Corning, Medfield, Massachusetts; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.-Reference-Cited by-同舟云学术

Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial fn1fn1This study was supported by Genentech, Inc., South San Francisco, California; Bayer Corporation, New York, New York; CIBA-Corning, Medfield, Massachusetts; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.

Published:1998-03 Issue:3 Volume:31 Page:497-505
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Granger Christopher B.,Becker Richard,Tracy Russell P.,Califf Robert M.,Topol Eric J.,Pieper Karen S.,Ross Allan M.,Roth Sherryn,Lambrew Costas,Bovill Edwin G.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Paradoxic elevation of fibrinopeptide A after streptokinase;Eisenberg;J Am Coll Cardiol,1987

2. Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis;Eisenberg;J Am Coll Cardiol,1986

3. Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator;Rapold;Circulation,1989

4. Rapold HJ, de Bono D, Arnold AER, et al., for the European Cooperative Study Group. Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase: correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. Circulation 1992;85:928–34.

5. Heparin-induced prolongation of partial thromboplastin time after thrombolysis;Hsia;J Am Coll Cardiol,1992

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attenuation of Atherosclerosis with PAR4 Deficiency: Differential Platelet Outcomes in apoE^-/-vs. Ldlr^-/-Mice;2024-08-07

2. Blood clot properties, thrombin generation, and platelet activation in patients with dysglycemia and established atherosclerotic cardiovascular disease: The CASCARA study;Polish Heart Journal;2024-06-28

3. Plasma levels of thrombin and activated protein C in patients with acute myocardial Infarction: An observational study;IJC Heart & Vasculature;2022-10

4. Enhanced Thrombin Generation Is Associated with Worse Left Ventricular Scarring after ST-Segment Elevation Myocardial Infarction: A Cohort Study;Pharmaceuticals;2022-06-06

5. Catheter-Directed Thrombolysis for Postpartum Deep Venous Thrombosis;Frontiers in Cardiovascular Medicine;2022-04-26